Component

Cytosine oxidation products in human HAP1 TET-knockout cells

5-hydroxymethylcytosine and 5-formylcytosine measured by 2D-UPLC-MS/MS.

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. TET2 knockout in human HAP1 cells lowered 5-hydroxymethylcytosine and 5-formylcytosine measured by 2D-UPLC-MS/MS, and vitamin C treatment did not restore them to the levels seen in treated wild-type cells, so loss of one TET paralog was not compensated by the remaining ones.

    Experimental context and source evidence
    availability_state
    machinery_impairment Imported condition classification; unverified.
    duration
    Culture experiments
    experimental_model
    Human HAP1 cells with single and double TET knockouts
    exposure
    Vitamin C treatment of wild-type and TET-knockout cells
    limitations
    A near-haploid cell line, not a haematopoietic cell; a knockout is not a patient's point mutation.
    organism
    Homo sapiens
    plain_language
    Vitamin C cannot fully substitute for a TET2 that is missing.
    primary_references
    [kusmierek-2025] Loss of TET2 activity limits the ability of vitamin C to activate DNA demethylation in human HAP1 cells (2025). https://pubmed.ncbi.nlm.nih.gov/41287077/ DOI: 10.1186/s13072-025-00634-1
    tissue
    HAP1 cell line
    trigger_kind
    machinery_impairment Imported condition classification; unverified.

    TET2 loss and malignancy: the step between a nutrient-responsive enzyme and the disease (2026-09-23) · lines 183–191

    Original AI-assisted curation of twelve primary studies located by Europe PMC title search, with every statement drafted from the retrieved abstract. Two pairs share a laboratory and are recorded as one line of evidence each. Genetic loss of function, pharmacological exposure and dietary depletion are kept as separate record types. Not publisher full text. · supports · Human HAP1 cells with single and double TET knockouts · source_derived_draft · unverified_draft

    ## vitamin-c-cannot-replace-lost-tet2 TET2 knockout in human HAP1 cells lowered 5-hydroxymethylcytosine and 5-formylcytosine measured by 2D-UPLC-MS/MS, and vitamin C treatment did not restore them to the levels seen in treated wild-type cells, so loss of one TET paralog was not compensated by the remaining ones. Model/species: Human HAP1 cells with single and double TET knockouts Organism: Homo sapiens Tissue/system: HAP1 cell line Exposure: Vitamin C treatment of wild-type and TET-knockout cells Duration: Culture experiments Limits: A near-haploid cell line, not a haematopoietic cell; a knockout is not a patient's point mutation. Primary reference: [kusmierek-2025] Loss of TET2 activity limits the ability of vitamin C to activate DNA demethylation in human HAP1 cells (2025). https://pubmed.ncbi.nlm.nih.gov/41287077/ DOI: 10.1186/s13072-025-00634-1
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards